Papapetropoulos, Spyros

Center for Neurosciences

Citations 6

Refining the phenotype of adult-onset leukoencephalopathy with axonal spheroids and pigmented glia (ALSP), a commonly misdiagnosed autosomal dominant neurodegenerative disease (S49.010)

Neurology | April 28, 2023 | Volume: 100 | Issue: 17_supplement_2 | Pages: No page available

10.1212/wnl.0000000000203602

Adult-onset leukoencephalopathy with axonal spheroids and pigmented glia (ALSP) is commonly misdiagnosed as Frontotemporal Dementia (FTD), Multiple Sclerosis (MS,) Alzheimer’s disease (AD), or other adult-onset leukodystrophies (P12-4.003)

Neurology | April 28, 2023 | Volume: 100 | Issue: 17_supplement_2 | Pages: No page available

10.1212/wnl.0000000000203549

Radiological features of adult-onset leukoencephalopathy with axonal spheroids and pigmented glia (ALSP) and its longitudinal progression (P8-4.003)

Neurology | April 28, 2023 | Volume: 100 | Issue: 17_supplement_2 | Pages: No page available

10.1212/wnl.0000000000203119

A Prospective Natural History Study of Patients with Adult-Onset Leukoencephalopathy with Axonal Spheroids and Pigmented Glia (ALSP) (S49.008)

Neurology | April 28, 2023 | Volume: 100 | Issue: 17_supplement_2 | Pages: No page available

10.1212/wnl.0000000000203073

MAPT H1 haplotype is a risk factor for essential tremor and multiple system atrophy

Neurology | February 15, 2011 | Volume: 76 | Issue: 7 | Pages: 670-672

10.1212/wnl.0b013e31820c30c1 | PMID 21321341

PGC-1 α, A Potential Therapeutic Target for Early Intervention in Parkinson’s Disease

Science Translational Medicine | October 6, 2010 | Volume: 2 | Issue: 52 | Pages: No page available

10.1126/scitranslmed.3001059 | PMID 20926834

Abnormal expression of genes for energy regulation in Parkinson’s disease patients identifies a master regulator as a possible therapeutic target for early intervention.